- Home
- SUPN vs LFST Comparison
SUPN vs LFST Comparison
Compare SUPN & LFST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUPN
- LFST
- Stock Information
- Founded
- SUPN 2005
- LFST 2015
- Country
- SUPN United States
- LFST United States
- Employees
- SUPN N/A
- LFST N/A
- Industry
- SUPN Biotechnology: Pharmaceutical Preparations
- LFST Medical/Nursing Services
- Sector
- SUPN Health Care
- LFST Health Care
- Exchange
- SUPN Nasdaq
- LFST Nasdaq
- Market Cap
- SUPN 1.8B
- LFST 1.9B
- IPO Year
- SUPN 2012
- LFST 2021
- Fundamental
- Price
- SUPN $32.46
- LFST $4.72
- Analyst Decision
- SUPN Hold
- LFST Strong Buy
- Analyst Count
- SUPN 2
- LFST 5
- Target Price
- SUPN $36.00
- LFST $8.50
- AVG Volume (30 Days)
- SUPN 747.3K
- LFST 2.2M
- Earning Date
- SUPN 08-05-2025
- LFST 08-07-2025
- Dividend Yield
- SUPN N/A
- LFST N/A
- EPS Growth
- SUPN N/A
- LFST N/A
- EPS
- SUPN 1.11
- LFST N/A
- Revenue
- SUPN $667,997,000.00
- LFST $1,283,503,000.00
- Revenue This Year
- SUPN N/A
- LFST $15.27
- Revenue Next Year
- SUPN $12.02
- LFST $13.94
- P/E Ratio
- SUPN $29.24
- LFST N/A
- Revenue Growth
- SUPN 11.82
- LFST 16.31
- 52 Week Low
- SUPN $25.94
- LFST $4.62
- 52 Week High
- SUPN $40.28
- LFST $8.61
- Technical
- Relative Strength Index (RSI)
- SUPN 53.20
- LFST 31.19
- Support Level
- SUPN $31.35
- LFST $4.70
- Resistance Level
- SUPN $32.55
- LFST $4.80
- Average True Range (ATR)
- SUPN 0.91
- LFST 0.19
- MACD
- SUPN 0.04
- LFST -0.01
- Stochastic Oscillator
- SUPN 60.93
- LFST 5.74
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About LFST LifeStance Health Group Inc.
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. The group y has a single operating and reportable segment of mental health services.